SET/TAF-I Antikörper
Kurzübersicht für SET/TAF-I Antikörper (ABIN7468959)
Target
Alle SET/TAF-I (SET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Spezifität
- Knockdown/Knockout validation was supported by customer review data.
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human SET. The exact sequence is proprietary.
-
Isotyp
- IgG
-
-
anti-SET Nuclear Oncogene (SET) (AA 1-277) antibody
SET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (N-Term) antibodyVerified SET Reaktivität: Human WB, IHC, ELISA Wirt: Ziege Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Monoclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Ratte IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (AA 146-277) antibodySET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (N-Term) antibodySET Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) (AA 1-277) antibodySET Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal M1-F5 unconjugated
anti-SET Nuclear Oncogene (SET) (AA 147-235) antibodySET Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-SET Nuclear Oncogene (SET) antibodySET Reaktivität: Human, Maus, Ratte WB, FACS, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: A431 , H1299 , HeLa , HepG2 , Molt-4 , Neuro 2A , GL261 , C8D30 , NIH-3T3 , BCL-1 , Raw264.7 , C2C12 , PC-12 , Rat2 Validation: KO/KD
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.43 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
-
